BMS’s Mezigdomide Myeloma Data Give Glimpse Of CELMoD Future

Phase I/II Results Published In NEJM

 
• By Alaric DeArment
  
BMS published data from its Phase I/II study of mezigdomide in the New England Journal of Medicine • Source: Shutterstock

More from Anticancer

More from Therapy Areas